
A-836339
CAS No. 959746-77-1
A-836339( A836339 )
Catalog No. M16849 CAS No. 959746-77-1
A-836339 (A836339) is a potent and selective cannabinoid CB2 receptor agonist with Ki of 0.64 and 0.76 nM for human and rat CB2 receptors.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 140 | In Stock |
![]() ![]() |
10MG | 250 | In Stock |
![]() ![]() |
25MG | 421 | In Stock |
![]() ![]() |
50MG | 619 | In Stock |
![]() ![]() |
100MG | 880 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameA-836339
-
NoteResearch use only, not for human use.
-
Brief DescriptionA-836339 (A836339) is a potent and selective cannabinoid CB2 receptor agonist with Ki of 0.64 and 0.76 nM for human and rat CB2 receptors.
-
DescriptionA-836339 (A836339) is a potent and selective cannabinoid CB2 receptor agonist with Ki of 0.64 and 0.76 nM for human and rat CB2 receptors, displays 425- and 189-fold selectivity over CB1 receptor, respectively; exhibits full agonist efficacy (Emax=102%) with high potency (EC50=1.6 nM), greater potency than other CB2-selective ligands including JWH-015 and GW-842166X; exhibits a potent CB2 receptor-mediated antihyperalgesic effect in various animal pain models, also demonstrates efficacies in the chronic constrain injury (CCI) model of neuropathic pain.
-
In Vitro——
-
In Vivo——
-
SynonymsA836339
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number959746-77-1
-
Formula Weight310.4548
-
Molecular FormulaC16H26N2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 12 mg/mL
-
SMILESCC1=C(C)N(CCOC)/C(S1)=N/C(C2C(C)(C)C2(C)C)=O
-
Chemical NameCyclopropanecarboxamide, N-[3-(2-methoxyethyl)-4,5-dimethyl-2(3H)-thiazolylidene]-2,2,3,3-tetramethyl-, [N(Z)]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yao BB, et al. J Pharmacol Exp Ther. 2009 Jan;328(1):141-51.
2. McGaraughty S, et al. Neuroscience. 2009 Feb 18;158(4):1652-61.
3. Hsieh GC, et al. Br J Pharmacol. 2011 Jan;162(2):428-40.
molnova catalog



related products
-
CP-724714
CP-724714 is an effective and selective HER2/ErbB2 inhibitor (IC50: 10 nM), >640-fold selectivity against EGFR, Abl, InsR, PDGFR, IRG-1R, Src, VEGFR2, c-Met etc.
-
2-Arachidonoylglycer...
2-Arachidonoylglycerol activates neuronal cannabinoid receptors as a full agonist, and prevents the induction of long-term potentiation at CA3–CA1 synapses.
-
PrNMI
PrNMI is a peripherally restricted cannabinoid 1 receptor (CB1R) agonist.